LabTech(SH:688056)2025-04-24 13:30Financial Performance - The company's operating revenue for Q1 2025 was ¥99,050,789.19, a decrease of 6.09% compared to ¥105,478,954.63 in the same period last year[4] - Net profit attributable to shareholders increased by 10.30% to ¥12,766,699.84 from ¥11,574,778.68 year-on-year[4] - The basic earnings per share rose by 11.76% to ¥0.19, compared to ¥0.17 in the previous year[4] - Total operating revenue for Q1 2025 was ¥99,050,789.19, a decrease of 6.8% compared to ¥105,478,954.63 in Q1 2024[19] - Net profit for Q1 2025 increased to ¥12,766,699.84, up 10.3% from ¥11,574,778.68 in Q1 2024[20] - Basic and diluted earnings per share for Q1 2025 were both ¥0.19, compared to ¥0.17 in Q1 2024[21] - The company reported a total comprehensive income of ¥12,278,853.46 for Q1 2025, an increase from ¥11,698,038.01 in Q1 2024[21] Research and Development - Research and development expenses totaled ¥11,358,075.06, down 8.02% from ¥12,347,788.06, with R&D expenses accounting for 11.47% of operating revenue, a decrease of 0.24 percentage points[5] - Research and development expenses for Q1 2025 were ¥11,358,075.06, down from ¥12,347,788.06 in Q1 2024[20] Cash Flow and Liquidity - The net cash flow from operating activities was negative at -¥3,144,132.03, compared to -¥1,282,305.88 in the same period last year[4] - Cash flow from operating activities for Q1 2025 was negative at -¥3,144,132.03, worsening from -¥1,282,305.88 in Q1 2024[23] - Net cash flow from financing activities was -314,223.38, indicating a significant outflow[24] - The net increase in cash and cash equivalents was -31,930,462.23, reflecting a decrease in liquidity[24] - The ending balance of cash and cash equivalents was 254,655,508.23, down from the beginning balance of 286,585,970.46[24] - The impact of exchange rate changes on cash and cash equivalents was 66,272.80, showing some resilience against currency fluctuations[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥954,742,314.35, a slight decrease of 0.10% from ¥955,712,276.45 at the end of the previous year[5] - The company's current assets totaled CNY 770,603,668.73, compared to CNY 767,512,121.41 at the end of 2024, indicating a growth of approximately 0.27%[14] - The total liabilities decreased from CNY 138,123,645.32 to CNY 124,462,990.38, reflecting a reduction of about 9.87%[15] - The cash and cash equivalents were reported at CNY 256,033,636.45, down from CNY 288,549,367.12, representing a decline of approximately 11.3%[13] - Accounts receivable increased to CNY 59,858,827.85 from CNY 55,096,497.57, showing an increase of about 8.5%[14] - Inventory levels slightly rose to CNY 171,127,708.48 from CNY 170,415,498.94, indicating a marginal increase of 0.42%[14] - The company reported a significant increase in accounts payable from CNY 39,600,301.87 to CNY 47,945,740.77, which is an increase of approximately 20.5%[15] - The total equity remained stable at CNY 67,452,460.00, unchanged from the previous reporting period[15] Shareholder Information - The net assets attributable to shareholders increased by 1.55% to ¥830,279,323.97 from ¥817,588,631.13 at the end of the previous year[5] - The total number of ordinary shareholders at the end of the reporting period was 3,085[10] - The company's total equity attributable to shareholders increased to ¥830,279,323.97 from ¥817,588,631.13 year-over-year[16] Government Support and Future Outlook - The company received government subsidies amounting to ¥90,935.08, which are expected to have a continuous impact on profits[6] - The company has not disclosed any new product developments or market expansion strategies during this reporting period[12] - The company will not apply new accounting standards starting from 2025, maintaining current reporting practices[24]